Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21
- PMID: 21378977
- PMCID: PMC3977039
- DOI: 10.1038/nm.2312
Fetal-specific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21
Abstract
The trials performed worldwide toward noninvasive prenatal diagnosis (NIPD) of Down's syndrome (or trisomy 21) have shown the commercial and medical potential of NIPD compared to the currently used invasive prenatal diagnostic procedures. Extensive investigation of methylation differences between the mother and the fetus has led to the identification of differentially methylated regions (DMRs). In this study, we present a strategy using the methylated DNA immunoprecipitation (MeDiP) methodology in combination with real-time quantitative PCR (qPCR) to achieve fetal chromosome dosage assessment, which can be performed noninvasively through the analysis of fetal-specific DMRs. We achieved noninvasive prenatal detection of trisomy 21 by determining the methylation ratio of normal and trisomy 21 cases for each tested fetal-specific DMR present in maternal peripheral blood, followed by further statistical analysis. The application of this fetal-specific methylation ratio approach provided correct diagnosis of 14 trisomy 21 and 26 normal cases.
Figures
Comment in
-
A new era of non-invasive prenatal genetic diagnosis: exploiting fetal epigenetic differences.Clin Genet. 2012 Apr;81(4):362-3. doi: 10.1111/j.1399-0004.2011.01835.x. Epub 2012 Jan 16. Clin Genet. 2012. PMID: 22171618 No abstract available.
-
Technical concerns about immunoprecipitation of methylated fetal DNA for noninvasive trisomy 21 diagnosis.Nat Med. 2012 Sep;18(9):1327-8; author reply 1328-9. doi: 10.1038/nm.2915. Nat Med. 2012. PMID: 22961155 No abstract available.
References
-
- Hulten MA, Dhanjal S, Pertl B. Rapid and simple prenatal diagnosis of common chromosome disorders: advantages and disadvantages of the molecular methods FISH and QF-PCR. Reproduction. 2003;126:279–297. - PubMed
-
- Lo YM, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485–487. - PubMed
-
- Honda H, et al. Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum. Hum. Genet. 2002;110:75–79. - PubMed
-
- Bianchi DW, Avent ND, Costa JM, van der Schoot CE. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time. Obstetrics and gynecology. 2005;106:841–844. - PubMed
-
- Lo YM, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. The New England journal of medicine. 1998;339:1734–1738. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
